{"title":"抗肿瘤坏死因子生物药对贝赫切特患者葡萄膜炎严重程度的影响:系统综述和 Meta 分析。","authors":"Somayeh Abolhasani, Alireza Khabbazi, Foroogh Hosseini, Shiva Gholizadeh-Ghaleh Aziz, Shahriar Alipour","doi":"10.18240/ijo.2022.05.19","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To investigate effects of anti-TNF biologic drugs on uveitis severity (comparing visual acuity logMAR levels) in Behçet patients.</p><p><strong>Methods: </strong>Three databases PubMed, Scopus, and the Web of Science were searched for qualified papers focusing on the anti-TNF-α factors treatment in Behçet's disease (BD)-associated uveitis. Studies that were designed pre and post anti-TNF drug treatment, were selected. After determining the search strategy for this study, the relevant data were extracted.</p><p><strong>Results: </strong>The initial search was performed in the target databases and a total of about 1458 articles were found. Fifteen articles were selected for systematic review and only 12 of them had inclusion criteria for Meta-analysis (with visual acuity data). The mean dose of prednisolone before and after biological treatments was reported in 5 studies (28.56 and 7.56 mg/kg, respectively). Also, the preliminary results indicate a significant reduction in visual acuity logMAR levels (MD=-1.5 IU/L, 95%CI: -2.1, -0.01).</p><p><strong>Conclusion: </strong>Biological drugs significantly reduce the dose of prednisolone and affect visual acuity values.</p>","PeriodicalId":15471,"journal":{"name":"Journal of Clinical Urology","volume":"15 1","pages":"813-819"},"PeriodicalIF":0.2000,"publicationDate":"2022-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091884/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effects of anti-TNF biologic drugs on uveitis severity in Behçet patients: systematic review and Meta-analysis.\",\"authors\":\"Somayeh Abolhasani, Alireza Khabbazi, Foroogh Hosseini, Shiva Gholizadeh-Ghaleh Aziz, Shahriar Alipour\",\"doi\":\"10.18240/ijo.2022.05.19\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>To investigate effects of anti-TNF biologic drugs on uveitis severity (comparing visual acuity logMAR levels) in Behçet patients.</p><p><strong>Methods: </strong>Three databases PubMed, Scopus, and the Web of Science were searched for qualified papers focusing on the anti-TNF-α factors treatment in Behçet's disease (BD)-associated uveitis. Studies that were designed pre and post anti-TNF drug treatment, were selected. After determining the search strategy for this study, the relevant data were extracted.</p><p><strong>Results: </strong>The initial search was performed in the target databases and a total of about 1458 articles were found. Fifteen articles were selected for systematic review and only 12 of them had inclusion criteria for Meta-analysis (with visual acuity data). The mean dose of prednisolone before and after biological treatments was reported in 5 studies (28.56 and 7.56 mg/kg, respectively). Also, the preliminary results indicate a significant reduction in visual acuity logMAR levels (MD=-1.5 IU/L, 95%CI: -2.1, -0.01).</p><p><strong>Conclusion: </strong>Biological drugs significantly reduce the dose of prednisolone and affect visual acuity values.</p>\",\"PeriodicalId\":15471,\"journal\":{\"name\":\"Journal of Clinical Urology\",\"volume\":\"15 1\",\"pages\":\"813-819\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091884/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.18240/ijo.2022.05.19\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2022.05.19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:研究抗肿瘤坏死因子(anti-TNF)生物药对贝赫切特病患葡萄膜炎严重程度的影响(比较视力对数):方法:在 PubMed、Scopus 和 Web of Science 三个数据库中搜索符合要求的论文,重点关注抗肿瘤坏死因子-α 因子治疗贝赫切特病(BD)相关葡萄膜炎的情况。选择了抗肿瘤坏死因子药物治疗前后的研究。在确定本研究的检索策略后,提取了相关数据:在目标数据库中进行了初步搜索,共找到约 1458 篇文章。结果:在目标数据库中进行了初步搜索,共找到约 1458 篇文章,其中 15 篇文章被选中进行系统性审查,只有 12 篇文章符合 Meta 分析的纳入标准(包含视力数据)。有 5 项研究报告了生物治疗前后泼尼松龙的平均剂量(分别为 28.56 毫克/千克和 7.56 毫克/千克)。此外,初步结果表明,视敏度 logMAR 水平显著降低(MD=-1.5 IU/L,95%CI:-2.1,-0.01):结论:生物药物可明显减少泼尼松龙的剂量,并影响视力值。
Effects of anti-TNF biologic drugs on uveitis severity in Behçet patients: systematic review and Meta-analysis.
Aim: To investigate effects of anti-TNF biologic drugs on uveitis severity (comparing visual acuity logMAR levels) in Behçet patients.
Methods: Three databases PubMed, Scopus, and the Web of Science were searched for qualified papers focusing on the anti-TNF-α factors treatment in Behçet's disease (BD)-associated uveitis. Studies that were designed pre and post anti-TNF drug treatment, were selected. After determining the search strategy for this study, the relevant data were extracted.
Results: The initial search was performed in the target databases and a total of about 1458 articles were found. Fifteen articles were selected for systematic review and only 12 of them had inclusion criteria for Meta-analysis (with visual acuity data). The mean dose of prednisolone before and after biological treatments was reported in 5 studies (28.56 and 7.56 mg/kg, respectively). Also, the preliminary results indicate a significant reduction in visual acuity logMAR levels (MD=-1.5 IU/L, 95%CI: -2.1, -0.01).
Conclusion: Biological drugs significantly reduce the dose of prednisolone and affect visual acuity values.